Linus Pauling, Ph.D. (1901–1994): From Chemical Bond to Civilization
Level 5 - mechanism / opinion, no new human data
Historical essay and narrative commentary without primary empirical data (graded by design analogy)
OpenAlex W2617724733 · doi:10.1176/appi.ajp.2017.17010093
What was done
This paper provides a historical and biographical review of Linus Pauling's conceptualization of orthomolecular psychiatry. It details his hypotheses regarding localized cerebral nutrient deficiencies (such as using megavitamin niacin therapy for schizophrenia), his personal medical background, the resulting 1973 American Psychiatric Association task force report, and subsequent debates with psychiatric researchers.
What was found
The abstract reports historical and theoretical context without quantitative metrics. It documents that Pauling's 1968 introduction of orthomolecular psychiatry met significant resistance from the psychiatric establishment, culminating in an APA task force report and critical commentaries in 1974 that rejected his proposals due to flawed underlying source methodologies and resistance to rigorous, controlled clinical trials.
Why it matters
The paper contextualizes the mid-20th-century transition of psychiatry toward biological and chemical frameworks, tracing how Pauling's molecular disease concepts influenced alternative psychiatric therapies and the debates surrounding megavitamin use.
Limits
This is a non-systematic historical commentary and biography containing no new experimental, observational, or clinical trial data. It does not quantitatively evaluate the efficacy of orthomolecular interventions.
Cited by
- supports Linus Pauling, Abram Hoffer, and David Hawkins created orthomolecular psychiatry in the 1970s to treat brain dysfunction using high doses of vitamins and minerals.